CAS# 86168-78-7
Also Known As GHRH(1-29)-NH₂
Class Synthetic GHRH Fragment
Form Lyophilized Powder
Receptor Target
Peptide Length
Molecular Weight
Sermorelin (GHRH(1-29)-NH₂, CAS# 86168-78-7) is a synthetic 29-amino acid amidated peptide corresponding to the biologically active N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH). It is studied in preclinical in vitro laboratory settings for its binding activity at the GHRH receptor (GHRHR) and related endocrine signalling pathway models. Supplied by NexPept as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Molecular Profile
CAS#, sequence, molecular weight, analytical data
CAS#, sequence, molecular weight, analytical data
| Property | Value |
|---|---|
| CAS Number | 86168-78-7 |
| IUPAC-Based Name | GHRH(1-29)-NH₂ — N-terminal fragment of growth hormone-releasing hormone |
| Compound Class | Synthetic GHRH fragment — amidated 29-amino acid peptide |
| Sequence Length | 29 amino acids (C-terminal amidation) |
| Molecular Weight | 3357.9 Da |
| Receptor Target | GHRHR (Growth Hormone-Releasing Hormone Receptor) |
| Physical Form | Lyophilized powder |
| Analytical Method | High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS) |
| Appearance | White to off-white lyophilized solid |
In Vitro Research Context
Receptor pharmacology — laboratory use only
Receptor pharmacology — laboratory use only
A G protein-coupled receptor (GPCR) expressed on anterior pituitary somatotroph cells. Sermorelin is studied for its binding activity at this receptor in the context of endocrine signalling pathway models, peptide–receptor interaction research, and structure–function studies of the GHRH peptide family.
Sermorelin is studied in preclinical in vitro settings as a pharmacological tool for investigating GHRH receptor binding and downstream signalling cascades. As the shortest biologically active fragment of GHRH known to retain full receptor binding activity, it is particularly relevant for structure–function research comparing native GHRH and its analogues in controlled experimental models.
Research context: Sermorelin is an investigational synthetic peptide studied in scientific research involving GHRHR signalling and endocrine pathway models. It has not been authorized by Health Canada for human or veterinary use.
Available Formats
10mg — lyophilized powder
10mg — lyophilized powder
| Format | Net Quantity | Physical Form |
|---|---|---|
| Sermorelin 10mg | 10 mg / vial | Lyophilized powder |
Sourced from a verified batch. Quantity for use should be determined based on your specific in vitro research protocol by qualified research personnel.
Laboratory Storage
Controlled storage conditions for lyophilized material
Controlled storage conditions for lyophilized material
Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from light and moisture. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.
Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Research Literature
Scientific references & related resources
Scientific references & related resources
Sermorelin Research Peptide Overview — NexPept compound overview and in vitro research context
PubMed — Sermorelin / GHRH(1-29) — peer-reviewed scientific literature on this compound
Research Peptides in Canada — sourcing and research context for Canadian laboratories
What Are Research Peptides? — peptide classification and in vitro research context
This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.
This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.
Be the first to review “Sermorelin 10mg”
Related products
Peptides
Reviews
There are no reviews yet.